D Ungheri Selected Research

Acetylcysteine (Siran)

4/2007	N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection.
1/2004	Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model.
9/2000	Protective effect of n-acetylcysteine in a model of influenza infection in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Ungheri Research Topics

Disease

3	Human Influenza (Influenza) 04/2007 - 09/2000
3	Infections 04/2007 - 09/2000
2	Virus Diseases (Viral Diseases) 04/2007 - 01/2004
2	Reinfection 07/2006 - 04/2005
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Urinary Tract Infections (Urinary Tract Infection) 01/2008
1	Persistent Infection 04/2005
1	Pneumonia (Pneumonitis) 01/2004

Drug/Important Bio-Agent (IBA)

3	Acetylcysteine (Siran)FDA LinkGeneric 04/2007 - 09/2000
3	AntioxidantsIBA 04/2007 - 09/2000
1	Fosfomycin FDA Link 01/2008
1	Anti-Infective Agents (Microbicides)IBA 01/2008
1	Oseltamivir (Tamiflu)FDA Link 04/2007
1	Antiviral Agents (Antivirals)IBA 04/2007
1	Immunoglobulin M (IgM)IBA 07/2006
1	Combined VaccinesIBA 07/2006
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2006
1	VaccinesIBA 04/2005
1	Therapeutic UsesIBA 04/2005
1	Ribavirin (Virazole)FDA LinkGeneric 01/2004
1	Interleukin-6 (Interleukin 6)IBA 09/2000
1	CytokinesIBA 09/2000
1	Xanthine OxidaseIBA 09/2000
1	Superoxides (Superoxide)IBA 09/2000
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2000

Therapy/Procedure

3	Therapeutics 01/2008 - 01/2004